FDA & Prescription Drugs
FDA Has Concerns Over Anti-Depressants
The Food and Drug Administration has requested that manufactures of leading anti-depressants add warnings to their labels to address recently discovered risks in newborns and migraine sufferers. The FDA’s concerns stem from a life threatening condition called serotonin syndrome, which has been linke